Page last updated: 2024-08-17

isosorbide dinitrate and Weight Gain

isosorbide dinitrate has been researched along with Weight Gain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bollmann, F; Daiber, A; Gori, T; Hausding, M; Heeren, T; Kleinert, H; Knorr, M; Münzel, T; Oelze, M; Otto, C; Pautz, A; Reifenberg, K; Schuhmacher, S; Schulz, E; Steven, S; Wenzel, P	1

Other Studies

1 other study(ies) available for isosorbide dinitrate and Weight Gain

Article	Year
Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy. Diabetes, 2011, Volume: 60, Issue:10 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Endothelium, Vascular; Gene Silencing; GTP Cyclohydrolase; Heme Oxygenase-1; Isosorbide Dinitrate; Male; NADPH Oxidases; Oxidative Stress; Pentaerythritol Tetranitrate; Rats; Rats, Wistar; Reactive Oxygen Species; Vasoconstriction; Vasodilator Agents; Weight Gain; Xanthine Oxidase	2011

Article

Year

Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy.

Diabetes, 2011, Volume: 60, Issue:10

Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Endothelium, Vascular; Gene Silencing; GTP Cyclohydrolase; Heme Oxygenase-1; Isosorbide Dinitrate; Male; NADPH Oxidases; Oxidative Stress; Pentaerythritol Tetranitrate; Rats; Rats, Wistar; Reactive Oxygen Species; Vasoconstriction; Vasodilator Agents; Weight Gain; Xanthine Oxidase

2011